Literature DB >> 32944139

Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action.

Etienne Billard1, David Chatenet1.   

Abstract

In the past few years, we have identified two allosteric modulators of the urotensinergic system with probe-dependent action, termed Urocontrin (UC) and Urocontrin A (UCA). Such action is atypical and important since it will allow us to understand the specific function of the functionally selective cognate ligands of this system, namely urotensin II and urotensin II-related peptide. Delineating the molecular determinants involved in this particular behavior would represent an important step toward designing small molecules suitable for pharmacologic and/or therapeutic intervention. Hence, we undertook an exploratory research by replacing the Trp4 residue of URP with several para-substituted phenylalanine amino acids in order to get a grasp on the required nature, distance, and orientation of the side chain of this residue for allosteric modulatory action. We found that the position of the second aromatic group is crucial, and we identified two new allosteric modulators: [Trip4]URP and [Phe(pPy-4)4]URP with probe-dependent action.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32944139      PMCID: PMC7488282          DOI: 10.1021/acsmedchemlett.0c00223

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  32 in total

1.  Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.

Authors:  Nicolas Bousette; Fu Hu; Eliot H Ohlstein; Dashyant Dhanak; Stephen A Douglas; Adel Giaid
Journal:  J Mol Cell Cardiol       Date:  2006-06-22       Impact factor: 5.000

2.  Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics.

Authors:  Antoine Douchez; Etienne Billard; Terence E Hébert; David Chatenet; William D Lubell
Journal:  J Med Chem       Date:  2017-12-05       Impact factor: 7.446

3.  Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease.

Authors:  Nicolas Bousette; Julia Pottinger; Wisam Ramli; Eliot H Ohlstein; Dashyant Dhanak; Stephen A Douglas; Adel Giaid
Journal:  Peptides       Date:  2006-08-17       Impact factor: 3.750

4.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.

Authors:  R S Ames; H M Sarau; J K Chambers; R N Willette; N V Aiyar; A M Romanic; C S Louden; J J Foley; C F Sauermelch; R W Coatney; Z Ao; J Disa; S D Holmes; J M Stadel; J D Martin; W S Liu; G I Glover; S Wilson; D E McNulty; C E Ellis; N A Elshourbagy; U Shabon; J J Trill; D W Hay; E H Ohlstein; D J Bergsma; S A Douglas
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

5.  Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.

Authors:  D Chatenet; M Létourneau; Q T Nguyen; N D Doan; J Dupuis; A Fournier
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.

Authors:  David Chatenet; Benjamin Folch; Debby Feytens; Myriam Létourneau; Dirk Tourwé; Nicolas Doucet; Alain Fournier
Journal:  J Med Chem       Date:  2013-11-26       Impact factor: 7.446

7.  Urocontrin, a novel UT receptor ligand with a unique pharmacological profile.

Authors:  David Chatenet; Quang-Trinh Nguyen; Myriam Létourneau; Jocelyn Dupuis; Alain Fournier
Journal:  Biochem Pharmacol       Date:  2011-12-16       Impact factor: 5.858

8.  Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides.

Authors:  Francesco Merlino; Étienne Billard; Ali M Yousif; Salvatore Di Maro; Diego Brancaccio; Luigi Abate; Alfonso Carotenuto; Rosa Bellavita; Roberta d'Emmanuele di Villa Bianca; Paolo Santicioli; Luciana Marinelli; Ettore Novellino; Terence E Hébert; William D Lubell; David Chatenet; Paolo Grieco
Journal:  J Med Chem       Date:  2019-01-23       Impact factor: 7.446

9.  The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation.

Authors:  Marie Jarry; Mickaël Diallo; Céline Lecointre; Laurence Desrues; Tursonjan Tokay; David Chatenet; Jérôme Leprince; Oriana Rossi; Hubert Vaudry; Marie-Christine Tonon; Laurent Prézeau; Hélène Castel; Pierrick Gandolfo
Journal:  Biochem J       Date:  2010-04-28       Impact factor: 3.857

10.  Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.

Authors:  Tsukasa Sugo; Yuko Murakami; Yukio Shimomura; Mioko Harada; Michiko Abe; Yoshihiro Ishibashi; Chieko Kitada; Nobuyuki Miyajima; Nobuhiro Suzuki; Masaaki Mori; Masahiko Fujino
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.